Alper Consultoria e Corretora de Seguros S.A. Stocks

R$ 46.75Last Updated 03.09.2024

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

R$ 179.43M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
R$ 46.75
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Alper Consultoria e Corretora de Seguros S.A. operates as an insurance brokerage company in Brazil. The company offers corporate risks insurance, including loss guarantees, financial lines, patrimonial, educational, and other products; corporate health benefits for large, medium, and small companies; auto insurance for fleet and individual vehicles; cargo insurance for national and international transportation; and personal insurance through retail partners. It also provides insurance for health, dental, life, civil liability, engineering risk, and other products. The company was formerly known as BR Insurance Corretora de Seguros S.A. and changed its name to Alper Consultoria e Corretora de Seguros S.A. in December 2018. Alper Consultoria e Corretora de Seguros S.A. was incorporated in 2010 and is based in São Paulo, Brazil.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks